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Human adaptive natural killer (NK) cells have diminished reliance on accessory cytokines
for their activation whilst being efficiently activated by infected host cells in conjunction
with pathogen specific antibodies. Here, we show that potent antibody-dependent
NK cell responses are induced by Plasmodium falciparum infected erythrocytes
(iRBC) in peripheral blood mononuclear cells (PBMC) from malaria-exposed Gambian
individuals in the presence of autologous sera, which are absent in those from
malaria-naïve UK individuals. However, malaria hyper-immune serum promotes rapid NK
cell responses to iRBC in cells from both Gambian and UK individuals. Among Gambians,
highly differentiated, adaptive (CD56dimFcεR1γ-CD57+) NK cells dominate both
antibody-dependent NK cell IFN-γ responses and degranulation responses, whereas
among UK individuals these responses are predominantly found within canonical,
highly differentiated CD56dimFcεR1γ+CD57+ NK cells. Indeed, overall frequencies of
adaptive, FcεR1γ-CD57+ NK cells are significantly higher among Gambian donors
compared to HCMV-infected and HCMV-uninfected UK adults. Among UK individuals,
antibody-dependent NK cell IFN-γ responses to iRBC were dependent on IL-18 whereas
among Gambians, the predominant adaptive FcεR1γ- NK cell response was IL-18 (and
accessory cell) independent (although the lower frequency response of canonical FcεR1γ
NK cells did rely on this cytokine).
Keywords: NK cells, Plasmodium falciparum, IL-18, FcεR1γ, CD57
INTRODUCTION
Natural killer cells integrate signals from both inflammatory mediators and acquired T and B
cell responses, enabling them to bridge innate and adaptive immunity, however, the intrinsic
differentiation state of these cells determines which combinations of signals contribute to their
activation and function (1). In human peripheral blood CD56bright NK cells are a minor
population and considered as the least differentiated subset. These cells respond predominately
to innate cytokines and T cell-derived interleukin-2 (IL-2) via constitutive expression of receptors
for IL-12 and IL-18, together with the high affinity CD25/CD122 complex for IL-2 (1). Only
rare populations of CD56bright cells respond to antibody-dependent signals, and only in some
individuals. In contrast, circulating CD56dim cells almost universally express CD16 (FcγRIIIA)
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and have reduced constitutive expression of cytokine receptors
(1). There is, however, considerable additional diversity within
CD56dim NK cells: progressive acquisition of CD57, a cell
surface moiety expressed with increasing differentiation, is
associated with higher expression of CD16 and further reductions
in cytokine receptor expression and cytokine responsiveness
(2, 3). Human cytomegalovirus infection is strongly associated
with further diversification of the natural killer cell repertoire
(4–7) including expansion of populations of CD57+NK cells
bearing the c-type lectin-like receptor, NKG2C. Ultimately, this
subset is highly represented amongst adaptive NK cells, which
have lost expression of the proteomyeloid zinc finger (PLZF)
molecule and the membrane adaptor protein FcεR1γ, switching
to usage of components of the PI3 kinase signaling cascade
including CD3ζ and ZAP70 and which can mount antibody
dependent responses independently of cytokines (6, 7). Indeed
the expression of transcripts for IL-12 and IL-18 receptors and
associated signaling components is lost in adaptive NK cells (7).
Acquisition of non-sterilizing immunity to malaria is
characterized by a progressive reduction of inflammation with
the gradual development of acquired cellular and humoral
responses (8, 9). Immune responses to erythrocytic stages of the
parasite lifecycle are associated with naturally acquired immunity
(10). Pathogen- associated molecular patterns from blood stage
P. falciparum parasites, either alone or in association with
haemozoin (the residue of hemoglobin digestion by the parasite),
are potent inducers of NK cell activating cytokines, including IL-
12, IL-18, and type 1 interferons (11–13). Inflammatory cytokines
are associated both with control of blood stage parasitaemia and
with onset of malaria pathology (14–19) but tend to diminish
in concentration with increasing levels of exposure and clinical
immunity. On the other hand, malaria-specific IgG1 and IgG3
antibodies with the potential to induce antibody dependent
cellular cytotoxicity (ADCC) have long been described to be
potentially protective against malaria (20, 21).
Natural killer cells are rapidly activated during controlled
human malaria infections of malaria non-immune individuals
and in vitro by P. falciparum infected erythrocytes (22–26). A
common feature of all of these models is contact-dependent
and cytokine-dependent activation of less differentiated NK cells
(CD56bright or CD56dimNKG2A+KIR–) by myeloid accessory
cells (22, 23, 27, 28). More recently, the role of antibody
in targeting P. falciparum merozoites and iRBC for growth
inhibition and killing by human natural killer cells has been
demonstrated, with significant contributions of responses to the
variable, erythrocyte surface-expressedmalaria antigens, PfEMP1
and RIFIN (29). Moreover, frequencies of FcεR1γ- adaptive
NK cells correlated with lower parasitaemia and resistance to
malaria in prospective studies in Mali and increasing frequencies
of PLZF- adaptive NK cells were associated with longer term
resistance (30).
In addition to their efficient lysis of iRBCs and inhibition
of parasite growth, adaptive NK cells may also contribute to
Abbreviations: NK, natural killer; P. falciparum, Plasmodium falciparum; uRBC,
uninfected red blood cells; iRBC, infected red blood cells, IL-18, Interleukin 18;
ADCC, antibody dependent cellular cytotoxicity.
effective antimalarial immunity due to their reduced reliance
on inflammatory cytokines, which contribute to malarial
disease. Our previous studies have shown that NK cell
differentiation proceeds rapidly in early life in a Gambian
population, with near-maximal frequencies of CD57+NKG2C+
cells observed by the age of 10 years and coincident loss of
NK cell responsiveness to exogenous IL-12 and IL-18 (31).
We hypothesized that in vitro responses of less differentiated
NK cells to P. falciparum-infected erythrocytes would be
strongly dependent on accessory cytokines for their activation,
whilst more differentiated subsets would progressively lose this
dependence with adaptive NK cells making potent antibody-
dependent but cytokine-independent responses. We therefore
compared NK cell differentiation phenotype and in vitro
responses to P. falciparum-infected erythrocytes in Gambian and
European individuals in the presence or absence of autologous
serum antibody.
We observed high frequencies of FcεR1γ- adaptive NK
cells and potent antibody-mediated anti-malarial NK cell
responses in Gambian individuals compared to European
donors. However, NK cell activation with iRBC in the presence
of a standard malaria hyper-immune serum stimulated
potent NK cell degranulation and IFN-γ production in both
Gambian and UK individuals. In UK individuals, responses
were strongest in CD56dimCD57+ NK cells, and required
endogenously produced IL-18 but not IL-12. In contrast,
in Gambian adults, adaptive NK cells dominated antibody-
dependent degranulation and IFN-γ responses and were
IL-18 independent. These data demonstrate for the first
time that IL-18 synergises for antibody-dependent activation
of canonical FcεR1γ+ NK cells by P. falciparum but that
subsequent maturation of NK cells to the adaptive FcεR1γ-
state has the potential to uncouple these responses from
the inflammatory cascade, thereby facilitating clearance
of iRBC without the need for induction of pathogenic
inflammatory cytokines.
MATERIALS AND METHODS
Study Subjects
Heparinized blood samples were collected from 26 healthy
Gambian adults (13 male; 13 female, mean age ± SD =
30.3 ± 8.7) as part of a previously published field study
(31), and from 15 HCMV seropositive (7 male; 8 female,
mean age ± SD = 36.3 ± 10.3) and 17 HCMV seronegative
(7 male; 11 female, mean age ± SD = 38.0 ± 10.3)
healthy UK volunteers. Samples were centrifuged and separated
into plasma and peripheral blood mononuclear cells (PBMC)
and cryopreserved. Exclusion criteria included known chronic
disease, confirmed infections during the previous 3 months or an
axillary temperature of≥38◦C. All Gambian subjects were shown
to be negative for malaria infections by thick blood smear. These
studies were approved by the London School of Hygiene and
Tropical Medicine Research Ethics Committee and the Gambia
Government/MRC Gambia Joint Ethics Committees (references
6034, 6237, and SCC1449v2).
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Cell Preparation
PBMC were isolated by standard ficoll hypaque centrifugation
and cryopreserved in 5% DMSO in fetal calf serum at −80◦C
overnight in Mr. FrostyTM freezing containers prior to transfer
into liquid nitrogen. Cells were recovered by thawing rapidly into
culture medium and repeated washing, and were rested at room
temperature for 3 h prior to stimulation. Viability of recovered
cells was >95% and yields ranged from 30 to 65%. NK cells were
enriched from PBMC of 6 Gambian individuals using an NK
cell purification kit in accordance with manufacturers protocols
(Miltenyi Biotech, UK). NK cell purities were (mean ± sd) 88%
± 6% of viable lymphocytes.
Plasma Samples and Serological Assays
HCMV serostatus of Gambian and UK study subjects was
confirmed using a commercially available ELISA to detect anti-
HCMV IgG (Demeditec, Germany). All 26 Gambian individuals
studied were confirmed to be HCMV seropositive and were
also found to have prior exposure to Plasmodium falciparum
malaria as demonstrated by seropositivity for IgG antibodies to P.
falciparum apical merozoite antigen 1 (AMA-1) using a validated
in house ELISA assay. Samples from HCMV- and HCMV+ UK
were selected to reflect a similar distribution of age and sex to
Gambian samples.
Parasite Cultures and Parasite Enrichment
Uninfected erythrocytes (uRBC) were obtained from the
National Blood Service, London, UK on a weekly basis and stored
at 4◦C. Erythrocytes infected with P. falciparum strain NF54 were
routinely synchronized and cultured at 5% haematocrit, 0.5–
2.5% parasitaemia in 75ml filtered top flasks (Nunc) according
to published protocols (32) and were tested regularly for
Mycoplasma spp. contamination using LookOut Mycoplasma
QPCR Detection Kit (Sigma-Aldrich, UK). Parasitaemia was
monitored by microscopic examination of methanol-fixed,
Giemsa-stained blood films. Late-stage schizonts were harvested
from cultures of 10–12% parasitaemia via centrifugation over
65% warmed Percoll solution (2,500 g for 10min without brake),
were washed twice in culture medium to remove any traces
of Percoll These were then cultured by mixing with fresh red
blood cells in culture medium and letting parasites invade
for 4–5 h followed by subsequent treatment with 5% sorbitol
to remove parasites that had not re-invaded. Synchronous
cultures (5–10% parasitaemia) were then grown for a further
38 h and trophozoites and early schizont stages harvested by
percoll purification.
In vitro Stimulation of NK Cells
PBMC or purified NK cells were cultured with uninfected
(uRBC) or P. falciparum-infected erythrocytes (iRBC) at a ratio
of 3 RBCs per leucocyte. Typically 4× 105 PBMC or purified NK
cells were used for each assay point.
For antibody-dependent assays, autologous plasma or aWHO
standard anti-malarial serum (National Institute for Biological
Standards and Control (NIBSC), UK; (33) was added to the
cultures at a final concentration of 1% (v/v) and the final
total serum concentration normalized to 5% in with FCS.
Negative control cultures contained FCS alone or antibody-
depleted autologous or anti-malarial serum (depleted of IgG
using a HiTrap R© protein G column, Merck, Sigma, UK). Overall
capacity for antibody-dependent NK cell activation was assessed
for each PBMC or NK cell sample using 100 ng/ml Rituximab
(Rituxan R©, Genetech, USA) and Raji B cells as targets (NIBSC,
UK) at a PBMC: target cell ratio of 5:1. For functional cytokine
blockade, a preservative-free, low endotoxin formulation of anti-
IL-12 (mIgG1, BD Biosciences, UK), anti-IL-18 (mIgG1, BD
Biosciences, UK) or isotype matched control antibody were
added at a final concentration of 3µg/ml for 30min prior
to stimulation. Cells were cultured for a total of 6 h. To
facilitate intracellular IFN-γ staining or CD107a accumulation,
Brefeldin A and Monensin (Both from BD Bioscience, UK) were
added after 1 h of culture at final concentrations of 1:1000 and
1:1500, respectively.
Flow Cytometric Analysis of NK Cells
Ex vivo or in vitro analysis of NK cell subsets was performed
using the following reagents: anti-CD3-V500 (clone UCHT1)
(BD Biosciences), anti-CD56-BV605 (clone HCD56), anti-IFN-
γ-BV785 (clone 4S.B3), anti-CD16-PeDazzle-594 (clone 3G8)
(all from Biolegend, London, U.K.); anti-CD16-APC (clone
CB16), anti-CD25-PerCPCy5.5 (clone BC96), anti-CD57-e450
(clone TB01), CD218-PE (anti-IL-18Rα) (clone H44) (all from
Thermo-Fisher) anti-NKG2C-PE (clone 134591) (R&D systems).
Rabbit polyclonal IgG anti-FcεR1γ FITC was obtained from
Millipore, UK. Anti-CD107a-e660 (clone 1D4B) (Biolegend)
was added to the culture at 2 µl per 100 µl for the whole
culture period.
For staining of cell surface markers, cells were harvested
into 96 well round-bottom tissue culture plates, washed in
FACS buffer (PBS, 0.5% FCS, 0.05% sodium azide, 2mM
EDTA) and Fc receptors blocked for 5min with Fc Receptor
(FcR) Blocking Reagent (Miltenyi Biotec). Reagents for surface
markers, supplemented with a fixable viability dye (Fixable
Viability Stain 700; BD Biosciences) were added to the cells
for 30min. Cells were washed in FACS buffer, fixed and
permeabilized according to the manufacturer’s instructions using
Cytofix/Cytoperm Kit (BD Biosciences) or Foxp3/Transcription
Factor Fixation/ Permeabilisation Kit (eBiosciences) and then
stained for intracellular markers with repeated FcR blockade for
20min. Finally, cells were washed and resuspended in FACS
buffer before acquisition on a BD LSRII flow cytometer using BD
FACSDiva software. Data were analyzed using FlowJo V10 (Tree
Star, Oregon, U.S.A). Flow cytometry gating was established
using FMO controls or unstimulated cells. Between 1,000 and
10,000 gated total NK cell events were acquired, equivalent to
790–9560 CD56dim cell events. For ex-vivo analysis, samples
with fewer than 100 events in each phenotyped NK cell subset
were excluded. For in vitro stimulations with iRBC+ immune
serum, a mean of 1940 CD107a+ and 320 IFN-γ+ CD56dim+
NK cells were acquired.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism version
7.04 (GraphPad, California, U.S.A.). Intergroup comparisons
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were made using Mann-Whitney U test and paired comparisons
between culture conditions or cell subsets were made using
Wilcoxon signed-rank test. Correlations were performed using
Spearman’s correlation analysis. Significance levels are assigned
as ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 for
all tests.
RESULTS
Our previous studies have demonstrated rapid differentiation
of peripheral blood NK cells in Gambian children with
frequencies and geometric mean fluorescence intensity
(MFI) for the late differentiation marker CD57 stabilizing
to levels reached in adult Gambians by the age of 14
years (31). With progressive differentiation and adaptation,
human NK cells demonstrate reduced responsiveness to
cytokines accompanied by enhanced antibody-dependent
activation (6, 7). We therefore hypothesized that highly
differentiated and adaptive NK cells would demonstrate
superior antibody dependent responses to P. falciparum
infected erythrocytes.
Antibody-Dependent Responses of
Gambian and UK Individuals
The ability of NK cells from Gambian and UK adults to mount
responses to Plasmodium falciparum infected erythrocytes
(iRBC) was tested within PBMC after 6 h of culture in the
presence or absence of autologous plasma. We observed low
frequency but significant induction of IFN-γ in NK cells
from Gambian donors in response to iRBC compared to
uninfected erythrocytes (uRBC) and these responses were
further enhanced in the presence of autologous plasma
(Figure 1A). Only occasional responses to iRBC were observed
in malaria-unexposed UK individuals either with or without
autologous plasma. Similar patterns of responses were observed
for degranulation with Gambians, again, having the highest
frequencies of CD107a+ cells in the presence of autologous
plasma (Figure 1B). By contrast, NK cells fromUK and Gambian
donors had a similar capacity to produce IFN-γ and to
degranulate in response to the control stimulus, Raji B cell tumor
+ Rituximab (Figures 1C,D).
Malaria Immune Serum Promotes
Antibody-Mediated Responses in Both
Gambian and UK Adults
To assess the impact of NK cell differentiation and adaptation
on antimalarial NK cell responses, responses to iRBC were
compared between NK cells from Gambian and UK adults in
the presence of a standard anti-malarial serum (Figure 2).
NK cells from both Gambian (Figures 2A–D) and UK
(Figures 2E–H) individuals mounted robust IFN-γ and
CD107a responses, with reciprocal reduction in the frequencies
and MFI for CD16 (FcγRIII) expression, in hyper-immune
serum (Figures 2A–H).
Enrichment of Highly Differentiated
Adaptive NK Cells in Gambian Adults
We next examined the frequencies of adaptive FcεR1γ- NK cell
subsets and the expression of the differentiation marker CD57
in 26 heathy Gambian adults gated as shown in Figures S1A–D
(Figures 3A,B) and compared these to the frequencies in 15
HCMV+ and 17 HCMV– UK adults (Figure 3C). Gambian
adults had the highest frequencies of highly differentiated,
adaptive FcεR1γ-CD57+ NK cells. HCMV-infected UK adults
had lower overall frequencies of adaptive cells and these
cells were observed only occasionally in HCMV– uninfected
individuals (Figure 3C). Reciprocally, higher frequencies of
FcεR1γ+CD57– were observed in UK individuals (especially
among HCMV-uninfected UK donors) with similar frequencies
of FcεR1γ-CD57– and FcεR1γ+CD57+ subsets being observed
in all groups (Figure 3C). We observed no difference in the
resting frequencies of CD56dim NK cells between Gambian,
UK HCMV+ and UK HCMV– individuals, indicating that the
differences in the proportions of canonical and adaptive NK
cells reflect redistributions within the CD56dim compartment
(Figure S1E).
Adaptive NK Cells Dominate the
Antibody-Dependent Responses of
Gambian Individuals
To assess the impact of differing subset distribution, we back-
gated on the IFN-γ+ and CD107a+ NK cell populations
to determine the frequencies of each NK cell subset among
the iRBC-responding population (Figure 4). For Gambian
adults, the highest frequencies of IFN-γ producing cells were
found within the highly differentiated, FcεR1γ-CD57+ subsets,
whereas for UK individuals IFN-γ was observed predominantly
within canonical FcεR1γ+CD57+ cells (Figure 4A). Similarly,
degranulation responses occurred predominantly within FcεR1γ-
CD57+ cells in Gambian donors but among the FcεR1γ+CD57+
subset in UK donors (Figure 4B). We saw no overall difference
in responses between HCMV+ and HCMV– UK individuals.
The overall distribution of responses for each group are
shown in Figure 4C. However, in two HCMV+ UK individuals
with expansions of adaptive NK cells, the NK cell response
to iRBC was similar (in subset distribution) to that of
the Gambian donors (Figures 4A,B). These two individuals
had similar ex vivo frequencies of NKG2C+ NK cells
to many of the Gambian donors, although the presence
of NKG2C expansions did not appear to influence the
distribution of FcεR1γ/CD57 defined responses of Gambian
donors (Figure 4D). These data are consistent with a functional
adaptation of HCMV-associated NK cell expansions toward
antibody dependent responses.
IL-18 Independence of Adaptive NK Cell
Responses to iRBC
The expression of key elements of cytokine signaling pathways,
particularly for IL-12 and IL-18, is lost in adaptive NK cells. We
therefore tested whether antibody-dependent responses of iRBC
were additionally supported by accessory cytokines. We cultured
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FIGURE 1 | Antibody-dependent NK cell responses to Plasmodium infected erythrocytes. (A,C) IFN-γ and (B,D) CD107a responses measured within gated
CD56dim NK cells of Gambian (n = 26) and HCMV+ (n = 15) and HCMV– (n = 17) UK individuals. (A,B) cells cultured either with uninfected (uRBC) or infected red
blood cells (iRBC) for 6 h in the presence of FCS or FCS supplemented 1% (v/v) autologous serum. (C,D) control cultures were incubated in medium alone or with Raji
B cells in the presence of Rituximab or isotype control reagent. Bars represent median values and symbols represent individual data points. Paired comparisons
between culture conditions were made using Wilcoxon signed rank test. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
PBMC from Gambian or UK subjects in the presence of malaria
immune serum and with neutralizing antibodies against IL-12,
IL-18, or isotype control antibodies (Figure 5). We observed
that, in UK individuals, IL-18 blockade reduced antibody-
dependent IFN-γ production to the background frequencies
observed in IgG-depleted serum (Figure 5A) and resulted in
a partial inhibition of degranulation (Figure 5C). Interestingly,
we observed no effect of IL-12 blockade on these responses
(Figures 5A,C) despite this cytokine having been previously
implicated in antibody-independent responses to P. falciparum
in UK individuals (22, 23). In contrast, blockade of neither
IL-18 nor IL-12 significantly reduced the frequencies of IFN-γ
or CD107a expressing total CD56dim NK cells responding to
iRBC in the presence of malaria immune serum in Gambian
subjects (Figures 5B,D). To further establish whether NK cell
subsets differ in their reliance on IL-18 for antibody-dependent
induction of IFN-γ production or CD107a expression by
iRBC, we examined the subset distribution of these responses
in Gambian individuals with or without IL-18 neutralization
(Figures 5E,F). Interestingly, IL-18 neutralization significantly
reduced frequencies of IFN-γ producing cells only within
the less differentiated, canonical, FcεR1γ+CD57– NK cell
subset (Figure 5E) and there was no significant impact of IL-
18 neutralization on the CD107a response in any NK cell
subset (Figure 5F). Back-gating on these responses revealed
an overall increase in representation of FcεR1γ-CD57+ NK
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FIGURE 2 | Antibody-dependent NK cell responses in the presence of malaria-immune standard serum. Frequencies of gated CD56dim NK cells expressing (A,E)
IFN-γ and (B,F) CD107a (C,G) CD16 and (D,H) the MFI for CD16 after 6 h of culture with iRBC in the absence or presence of 0.2% or 1% (v/v) standard
malaria-immune serum. Responses are shown for Gambian (A–D, n = 16) or UK (E–H, n = 16) individuals. UK HCMV– and HCMV+ individuals are indicated by open
and gray symbols, respectively.
FIGURE 3 | Distribution of canonical and adaptive NK cell subsets. (A,B) Gating strategy for NK cell subsets based on co-expression of FcεR1γ and CD57. (C)
Frequencies of canonical and adaptive NK cell subsets within CD56dim NK cells were determined in malaria- exposed Gambian (n = 26) and HCMV+ (n = 15) and
HCMV– (n = 17) malaria-unexposed UK adults. Bars represent median values and symbols represent individual data points. Comparisons between groups were
made using Mann-Whitney u test. **p < 0.01, ***p < 0.001, ****p < 0.0001.
cells within the NK cell IFN-γ in the presence of IL-18
neutralizing antibody but no impact on the CD107a response
(Figures 5G,H).
Adaptive NK Cells Dominate the
Antibody-Dependent Responses of
Purified Cells
We then examined the ability of purified NK cells from
Gambian individuals to mount antibody-dependent responses
to iRBC (Figure 6). Significant antibody-dependent IFN-γ and
degranulation responses were observed within purified NK
cells, indicating that these responses could occur independently
of accessory cell-derived factors (Figures 6A,B). Addition of
recombinant IL-18 revealed significant synergy between IL-
18 and malaria immune serum for IFN-γ production and
degranulation responses whereas only limited additive effects
were observed in the presence of antibody depleted serum
(Figures 6A,B). IFN-γ responses of PBMC or purified NK
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FIGURE 4 | Preferential responsiveness of adaptive NK cells in Gambian individuals. Distribution of (A) IFN-γ and (B) CD107a expression within back-gated NK cell
subsets from UK (n = 16) and Gambian individuals (n = 16, closed circles) after stimulation with iRBC in the presence of 1% pooled standard malaria immune
standard serum. (C) Distribution charts showing enrichment of IFN-γ and CD107a responses within FcεR1γ+CD57+ cells of UK individuals and within
FcεR1γ-CD57+ adaptive NK cells of Gambian individuals. (D) Frequencies of NKG2C+ NK cells in UK and Gambian individuals. (A,B,D) Bars represent median
values and symbols represent individual data points. HCMV− and HCMV+ UK individuals are represented by open and gray symbols. Comparisons between groups
were made using Mann-Whitney u test. ****p < 0.0001.
cells to iRBC + immune serum were enriched within gated
FcεR1γ-CD57+ NK cells compared to canonical NK cell
subsets whereas degranulation responses were more evenly
distributed across all FcεR1γ/CD57 defined CD56dim NK cells
subsets (Figures 6C,D). Interestingly, however, the addition of
exogenous IL-18 to PBMC or purified NK cells resulted in
increased frequencies of antibody-dependent IFN-γ producing
NK cells within all FcεR1γ/CD57 defined subsets, indicating that
adaptive NK cell responses could be augmented by relatively
high physiological concentrations of this cytokine (Figure 6C).
Relative to the overall distribution within total CD56dim NK
cells cultured with antibody depleted serum (Figure 6E), back-
gating of IFN-γ responses in malaria immune serum confirmed
an over-representation of FcεRγ-CD57+ NK cells (Figure 6F).
Interestingly, despite clear synergy with anti-malarial antibody,
the relative contribution of adaptive FcεRγ-CD57+ NK cells
to the overall IFN-γ response was reduced in the presence of
exogenous IL-18 (Figure 6G). These data are consistent with
accessory cell-independence for antibody-dependent responses
of adaptive NK cell responses to iRBC. An even subset
distribution was observed for degranulation responses in the
presence or absence of exogenous IL-18 (Figure S2).
IL-18Rα Distribution on NK Cell Subsets
To examine further the basis for IL-18 independence of
adaptive NK cells for antibody- dependent responses to
P. falciparum, we examined expression of IL-18Rα and CD16
within FcεR1γ/CD57-defined NK cell subsets (Figure 7).
Consistent with a lack of IL-18 involvement in antibody-
dependent responses of adaptive NK cells to P. falciparum,
we observed the lowest frequencies of IL-18Rα expressing
cells within adaptive FcεR1γ-CD57+ NK cells (Figure 7A).
The lowest MFI for IL-18Rα expression was observed in
highly differentiated canonical and adaptive NK cell subsets
(Figure 7C). In Gambians, a gradated increase in the frequency
of CD16 expression on CD56dim NK cells was observed with
FcεR1γ+CD57+ and FcεR1γ-CD57+ NK cells having the
highest proportion (Figure 7B). Interestingly the MFI for
CD16 was highest in canonical CD57+ NK cells (Figure 7D),
indicating that, although these cells were examined ex vivo,
CD16 may be more susceptible to downregulation on adaptive
NK cells in our study population.
Overall, these data support an important role for adaptive
NK cells in mounting antibody-dependent responses to P.
falciparum iRBC erythrocytes in a manner that is independent
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FIGURE 5 | Antibody-mediated adaptive NK cell responses to iRBC are IL-18 independent. Responses of UK (n = 12, A,B) or Gambian individuals (n = 12, C,D) to
iRBC in the presence of 1% pooled standard malaria immune serum or the same serum depleted of IgG. Responses of HCMV+ UK individuals are represented by
gray symbols. Cultures were treated either with isotype control reagent or anti-IL-12 or anti-IL-18 neutralizing antibodies and (A,C) IFN-γ or (B,D) CD107a measured
after 6 h of culture. (E,F) frequencies of (E) IFN-γ and (F) CD107a production within canonical or adaptive NK cell subsets measured after incubation with immune
serum in the presence of anti-IL-18 neutralizing or isotype control reagents. (G,H) back-gating of (G) IFN-γ producing cells or (H) CD107a expressing cells showing
the relative contributions of FcεR1γ/CD57 defined subsets to these responses. Bars represent median values and symbols represent individual data points. Paired
comparisons between conditions were made using Wilcoxon signed rank test. **p < 0.01, ***p < 0.001.
FIGURE 6 | Antibody-dependent responses of purified NK cells are enriched within adaptive NK cells. (A,B) Frequencies of CD56dim NK cells within PBMC or
purified NK cells producing (A) IFN-γ or (B) CD107a in response to iRBC in the presence of 1% pooled standard malaria immune serum or antibody depleted serum
and the effect of exogenous IL-18. (C,D) Frequencies of (C) IFN-γ+ and (D) CD107a+ NK cells responding within gated FcεR1γ/CD57 defined NK cell subsets. (E)
Overall subset distributions within total CD56dim NK cells cultured in the presence of antibody depleted serum. (F,G) FcεR1γ/CD57 defined subset distributions for
responses of PBMC or purified NK cells within back-gated IFN-γ producing cells: (F) iRBC + immune serum, (G) iRBC + immune serum + 10 ng/ml rIL-18. Data are
shown for matched PBMC and enriched NK cells from 6 Gambian individuals. Bars represent median values and symbols represent individual data points. Paired
comparisons between culture conditions were made using Wilcoxon Signed rank test. *p < 0.05.
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FIGURE 7 | Distribution of IL-18Rα and CD16 within NK cell subsets of Gambian individuals. Frequencies of (A) IL-18Rα and (B) CD16 expressing subsets were
measured ex vivo in 16 Gambian adults and are shown within gated CD56dim NK cells alongside (C,D) the corresponding MFI for these receptors. Bars represent
median values and symbols represent individual data points. Unbiased paired comparisons between subsets were made using Freidman’s test with Dunn’s correction
for multiple comparisons. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
of accessory cells and accessory-cell derived cytokines. These
findings therefore support a contribution of adaptive NK
cells to anti-malarial immunity which limits reliance on
inflammatory pathways.
DISCUSSION
Effective anti-malarial immunity is characterized by the ability
to prevent parasite multiplication and to kill and remove
parasites and iRBC whilst at the same time minimizing
inflammation and the consequent febrile response; this is
largely attributed to the gradual acquisition of populations
of regulatory cells that suppress inflammation (34) and to
a switch from predominately cell-mediated immune effector
mechanisms to antibody-mediated parasite clearance. However,
given the largely intracellular nature of the parasite lifecycle,
synergy between antibodies and cytotoxic/phagocytic cells is
more likely to lead to efficient clearance of infected cells than
purely antibody-mediated mechanisms such as neutralization
or complement fixation. The conundrum, therefore, is how to
ensure effective co-operation between antibodies and effector
cells without the need for inflammatory cytokines to activate
cytotoxicity and/or phagocytosis. This study begins to answer
this conundrum by demonstrating the impact of human NK
cell differentiation and adaptation on responses to malaria
parasites, enabling NK cell activation by antibody without
any need for cytokines. This study also begins to inform
the ongoing debate around differences in immune responses
between individuals living in “westernized” environments and
those living in low and middle income countries and the
consequences for vaccine efficacy (35–39). Specifically, this
study shows that African individuals possess significantly higher
frequencies of highly differentiated, adaptive (FcεR1γ-) NK cells
than either HCMV-infected or -uninfected UK individuals of
a similar age and that these differences in the distribution of
NK cell subsets impacts on their activation by P. falciparum-
infected erythrocytes, in particular their ability to be activated
by antigen-antibody complexes in the absence of inflammatory
cytokines. Our data are thus in line with recent studies
showing that purified NK cells can inhibit the growth of
P. falciparum in culture in a manner that is dependent
upon malaria-specific antibodies but independent of accessory
cells (29).
We have shown that malaria hyper-immune serum, but
not IgG-depleted immune serum, supported strong cytokine
and degranulation responses to iRBC by NK cells of both
malaria-exposed Gambians and malaria-naïve UK individuals,
confirming the importance of malaria specific antibody. Using
autologous plasma to support the antibody-dependent responses
to iRBC, the level of antibody to antigens expressed on the
erythrocyte surface is likely to contribute to differences in
magnitude of the NK cell response; clonally variant antigens
including PfEMP-1 and Rifins have been shown to contribute
to the antibody-dependent NK cell response (30). All of the
adult Gambians selected for this study were seropositive for
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the merozoite-expressed apical membrane antigen-1 (AMA-1),
as determined by ELISA. We observed no direct relationship
between the levels of anti-AMA-1 antibodies (or a further 17
conserved merozoite-expressed antigens) and the magnitude
of the NK cell response, consistent with the notion that
crosslinking of merozoite antigens does not make a major
contribution to NK activation by intact, parasitized RBCs (data
not shown).
NK cells from both Gambian and UK donors mount robust
antibody-dependent responses to malaria-infected erythrocytes
in the presence of a standard malaria hyper-immune sera.
However, different NK cell subsets dominate these responses
depending on the donor origin. In UK donors, differentiated
canonical FcεR1γ+CD57+ cells dominate antibody-dependent
responses, whereas in Gambian donors these responses occur
preferentially within adaptive FcεR1γ-CD57+ NK cells. Less
differentiated CD57–CD56dim– NK cells were the principal
subsets reliant on IL-18 for antibody-dependent responses in
both study populations. This is consistent with the previously
reported predominance of less differentiated CD56bright or
CD56dim CD57– NK cells in responses to cytokines (in the
absence of CD16 crosslinking) (2, 3, 31, 40). Remarkably,
and distinct from previous findings in murine P. chabaudi
malaria (41) early, antibody-dependent IFN-γ responses to
P. falciparum iRBC were entirely independent of IL-12 (and
IFN-αβR signaling, data not shown) within all NK cell
subsets. Previous studies have reported that IL-18, in particular,
synergises with antibody Fc receptor crosslinking for the
promotion of enhanced antibody-mediated NK cell responses
(3, 42): low concentrations of IL-18 synergised with CD16
cross-linking or antibody-mediated responses to inactivated
H3N2 influenza virus particles for enhanced IFN-γ, CD107a
and CD25 expression (3, 42). Whilst synergy between CD16-
mediated and IL-18-mediated signals promotes potent early NK
cell responses (within 6 h of in vitro culture), we cannot exclude
that the response kinetic differs for distinct adaptive or canonical
NK cell subsets (3). However, our data indicate that potent
NK cell IFN-γ and CD107a responses, with reciprocal down
regulation of CD16 expression. occur in both UK and Gambian
individuals within 6 h of culture with iRBC and malaria hyper-
immune serum. Synergy between CD16 and endogenous IL-18
may therefore be required to promote robust early responses
in canonical NK cells, but this may not required for the
optimal response of adaptive cells. Equally importantly, addition
of exogenous recombinant IL-18 to PBMC or purified NK
cell cultures indicates that higher physiological concentrations
of IL-18 may indeed influence the activation of adaptive
NK cells. CD16 associates with disulphide-linked homodimers
or heterodimers of the TCRζ and/or the FcRγ chains and
signaling is mediated via Src-family kinase-mediated tyrosine
phosphorylation ultimately leading to PI3K, Vav1, PLC-γ1, and
PLC-γ2 activation (43, 44). IL-18 utilizes the TIR domain
of MyD88 to access the NFκB signaling pathway (45, 46).
Importantly, our data indicate a significant role for endogenous
IL-18 on antibody mediated IFN-γ responses with only limited
effects of IL-18 neutralization on degranulation responses. It
is therefore likely that crosstalk between these pathways is
responsible of the enhancement of antibody mediated effects on
cytokine production.
Consistent with previous studies (2), IL-18Rα expression
in NK cells from Gambian individuals correlated with the
extent of NK cell differentiation. IL-18Rα+ NK cells are less
frequent (and the MFI of receptor expression is lower) in
more differentiated CD57+ NK cells, consistent with their
dependence on this cytokine for optimal antibody induced
IFN-γ production to iRBC but less so for degranulation.
It has been reported that targeting of HLA-E transfected
cell lines by CD56dim CD57+NKG2C+ NK cells, in the
absence of antibody-mediated signals, was enhanced by IL-
18, implying that “adaptive” NK cells defined by these
receptors maintain some components of the IL-18R signaling
pathway (47); these studies also reported maintenance of IL-
18RAP transcript expression in NKG2C+ NK cells, albeit
with reduced levels of NFκB phosphorylation (47). However,
in these studies “adaptive” NKG2C+ NK cells were not
classified according to FcεR1γ expression. In our study
NKG2C expressing NK cells are significantly more prevalent in
Gambian than in UK individuals and are equally represented
within the FCεR1γ+CD57+ canonical and FcεR1γ-CD57+
adaptive subset suggesting that CD56dim CD57+NKG2C+ NK
cells comprise both IL-18-dependent (FcεR1γ+) and IL-18-
independent (FcεR1γ-) subpopulations (Figure S3). We also
observed higher frequencies of CD2 expression within FcεR1γ-
CD57+ NK cells with the potential for LFA-3 mediated
interactions (Figure S3).
Whilst NK cell responses to iRBC vary between individuals
and between populations, this is only partially explained by
differences in the proportions of NK cells in particular NK
cell subsets. Even in controlled conditions, using standardized
parasite preparations and a standard hyper-immune serum,
and after accounting for differences in proportions of NK cell
subsets, there was considerable variation between individuals
in their response to iRBC. It is therefore likely that the
relationship between malaria-specific antibody and the extent
of NK cell activation is a complex one, which goes beyond
the magnitude of the antibody response and the intrinsic
capacity of distinct NK cell differentiation subsets to respond.
Variation in the frequencies of CD16+ NK cells and the
extent of CD16 expression within canonical and adaptive
NK cell subsets (see Figure 7) are likely to play a role in
determining the magnitude of antibody-dependent responses.
Whilst the vast majority of FcεR1γ-CD57+ adaptive NK cells
are CD16+, the MFI for CD16 expression was lower in
this subset than in the canonical FcεR1γ+ subset; this may
reflect more frequent cross-linking by immune complexes and
subsequent metalloprotease-mediated down-regulation of CD16
within adaptive NK cells in our Gambian study subjects,
consistent with previous reports (48, 49). Additionally, and
consistent with previous estimates in African populations
(50, 51), the frequency of the well-documented high affinity
158-V allele of CD16 is relatively high in our Gambian
study population and likely contributes to variation in both
expression of CD16 and the magnitude of the antibody-
dependent NK cell response. Finally, individual differences
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in the frequency and MFI of IL-18Rα expression on NK
cells, or frequencies of IL-18 producing accessory cells or
the overall concentration of IL-18, could also contribute to
variation in antibody-dependent responses, especially in the less
differentiated subsets.
In summary, there is accumulating evidence that NK cells
may play an important role in antibody-mediated control of
malaria infections and may be pivotal in ensuring clearance of
iRBC in situations where potentially damaging inflammatory
responses are down regulated. The quality of the antibody
response, in combination with the maturation status of the NK
cell population (which in itself is affected by prior infection
history) and the immune regulatory environment of the host
will all play a role in determining the effectiveness of these
ADCC mechanisms. This study is limited in that it does not
indicate whether NK cell-mediated ADCC or ADCI responses
contribute directly to anti-malarial immunity and future field
studies should compare Plasmodium specific antibody responses,
inflammatory cytokine measures, adaptive NK cell frequencies
and NK cell ADCC/ADCI responses in malaria immune and
non-immune individuals in an endemic setting. Further studies
should also address the nature of the antibodies and the NK
cells which most efficiently trigger NK cell-mediated killing of P.
falciparum iRBCs, and the impact of the cytokine environment
(both inflammatory and anti-inflammatory). These factors may
also be important in the context of malaria vaccines, where the
choice of adjuvant could influence the cytokine-induced pre-
activation of canonical NK cell subsets and population differences
in the frequencies of adaptive NK cells could impact their role as
effectors in the vaccine induced response. The impact of genetic
variation—diversity in HLA and killer cell immunoglobulin-
like receptors (52–54) as well as polymorphisms in other NK
cell receptors such as CD16 and NKG2C—on the diversity of
NK cell responses within and between populations should also
be considered.
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Figure S1 | Gating strategy and comparative frequencies of CD56dim NK cells.
(A) NK cell gate (B) CD56dim cell gate. (C) IFN-γ production and (D) CD107a
expression gates are shown. Data are shown for IFN-γ and CD107a responses to
iRBC in the presence or absence of malaria hyper immune serum at the indicated
concentrations (C,D). (E) Frequencies of gated CD56dim NK cells in Gambians
compared to UK HCMV+ and UK HCMV– individuals. Bars represent median
values and symbols represent individual data points.
Figure S2 | Impact of exogenous IL-18 on the subset distribution for CD107a
expression frequencies within PBMC and purified NK cells. Charts show the
distribution of FCεR1γ/CD57 defined subsets within gated CD107a+CD56dim NK
cells within PBMC or NK cells in the absence (A) or presence of exogenous IL-18
(B). Combined distributions are shown for 6 individuals.
Figure S3 | Ex vivo distribution of CD2 and NKG2C within FCεR1γ/CD57 defined
NK cell subsets. (A) NKG2C and (B) CD2 expression was monitored in gated NK
cell subsets in Gambian individuals (NKG2C, n = 16; CD2, n = 26). Bars
represent median values and symbols represent individual data points. Unbiased
paired comparisons between subsets were made using Freidman’s test with
Dunn’s correction for multiple comparisons. ∗∗p < 0.01, ∗∗∗p < 0.001 and
∗∗∗∗p < 0.0001.
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